Linders, D.; Deken, M.; van der Valk, M.; Tummers, W.; Bhairosingh, S.; Schaap, D.; van Lijnschoten, G.; Zonoobi, E.; Kuppen, P.; van de Velde, C.;
et al. CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy. Diagnostics 2021, 11, 516.
https://doi.org/10.3390/diagnostics11030516
AMA Style
Linders D, Deken M, van der Valk M, Tummers W, Bhairosingh S, Schaap D, van Lijnschoten G, Zonoobi E, Kuppen P, van de Velde C,
et al. CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy. Diagnostics. 2021; 11(3):516.
https://doi.org/10.3390/diagnostics11030516
Chicago/Turabian Style
Linders, Daan, Marion Deken, Maxime van der Valk, Willemieke Tummers, Shadhvi Bhairosingh, Dennis Schaap, Gesina van Lijnschoten, Elham Zonoobi, Peter Kuppen, Cornelis van de Velde,
and et al. 2021. "CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy" Diagnostics 11, no. 3: 516.
https://doi.org/10.3390/diagnostics11030516
APA Style
Linders, D., Deken, M., van der Valk, M., Tummers, W., Bhairosingh, S., Schaap, D., van Lijnschoten, G., Zonoobi, E., Kuppen, P., van de Velde, C., Vahrmeijer, A., Farina Sarasqueta, A., Sier, C., & Hilling, D.
(2021). CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy. Diagnostics, 11(3), 516.
https://doi.org/10.3390/diagnostics11030516
